Vivus

Vivus announces journal publication of Qsymia study results in type 2 diabetes
Seeking Alpha
Mon, 10/6/14 - 11:06 am
Vivus
Qsymia
type 2 diabetes
Faster-acting erectile dysfunction drug gets FDA approval
Yahoo/Reuters
Thu, 09/18/14 - 09:13 am
FDA
erectile dysfunction
Vivus
Auxilium
Stendra
Vivus acquires patent rights to Qsymia ingredient
Yahoo/AP
Mon, 08/25/14 - 09:54 am
Vivus
patents
Qsymia
Janssen
JNJ
VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales
Yahoo/Zacks.com
Fri, 08/8/14 - 11:40 am
Vivus
earnings
The Implications of Obesity as a Disability in Europe
Motley Fool
Sun, 07/20/14 - 09:10 am
obesity
weight loss
Arena Pharmaceuticals
Belviq
Orexigen
Vivus
Eisai
Qsymia
NB32
Vivus hits Actavis with Qsymia patent-infringement lawsuit
Fierce Pharma
Fri, 06/13/14 - 06:46 pm
patents
Vivus
Qsymia
Actavis
generics
Arena vs Vivus: Which Obesity Stock is a Buy? (video)
Motley Fool
Sat, 05/31/14 - 10:04 am
Arena Pharmaceuticals
Vivus
obesity
weight loss
Belviq
Qsymia
A Vivus Buyout? Fat Chance And A Good Time To Short
Seeking Alpha
Fri, 05/30/14 - 01:01 pm
Vivus
M&A
Today's Top Biotech Stocks to Watch: Intercept Pharmaceuticals and VIVUS
Motley Fool
Thu, 05/29/14 - 09:17 am
Vivus
Intercept Pharmaceuticals
M&A
Aspen Investments
OCA
A Greek Lawyer Managing a Little-Known Investment Fund Wants to Buy Vivus for $640 Million
TheStreet.com
Wed, 05/28/14 - 11:39 am
Vivus
M&A
Aspen Investments
Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why
Seeking Alpha
Wed, 05/28/14 - 09:45 am
obesity
Orexigen
FDA
Contrave
Vivus
Qsymia
Belviq
Arena Pharmaceuticals
The Future of Fat Fighting: Next-Gen Obesity Drugs
Motley Fool
Sun, 05/25/14 - 10:30 am
obesity
weight loss
Zafgen
beloranid
Arena
Vivus
Qsymia
Belviq
1 Obesity Drug Stock the Market Got Completely Wrong (video)
Motley Fool
Sun, 05/18/14 - 10:13 am
Vivus
Qsymia
weight loss
obesity
Vivus's diet pill faces generic threat from Actavis
Yahoo/Reuters
Fri, 05/9/14 - 10:34 am
Vivus
generics
obesity
Qsymia
Actavis
Will Arena Seize An Opportunity?
Seeking Alpha
Tue, 05/6/14 - 04:46 pm
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
obesity
Qsymia
Vivus Earnings On Tap
Seeking Alpha
Mon, 05/5/14 - 04:59 pm
earnings
Vivus
1 of These 3 Cratering Biotechs is a Buy
Motley Fool
Sun, 04/20/14 - 09:27 am
Halozyme
Exelixis
Vivus
Vivus needs more than boardroom shuffling to keep up with Arena's Belviq
Fierce Pharma
Mon, 04/14/14 - 08:42 am
Belviq
Vivus
obesity
Arena Pharmaceuticals
Qsymia
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Thu, 04/3/14 - 09:21 am
Medicines Company
Omeros
OPKO Health
Vivus
OMS721
Qsymia
Fibrocaps
Can Arena and VIVUS Profit From Glaxo's Troubles?
Motley Fool
Mon, 03/31/14 - 10:36 pm
Arena Pharmaceuticals
Vivus
GSK
Alli
tampering

Pages